Sp3 transcription factor is crucial for transcriptional activation of the human NOX4 gene

FEBS Journal

Volumn 278, Issue 6, 2011, Pages 964-972

  Katsuyama, Masato ^a   Hirai, Hideyo ^b   Iwata, Kazumi ^a   Ibi, Masakazu ^a   Matsuno, Kuniharu ^a   Matsumoto, Misaki ^a   Yabe Nishimura, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

GC box; NADPH oxidase; NOX4; Sp3; transcriptional regulation

Indexed keywords

CYTOSINE; GENOMIC DNA; GUANINE; KRUPPEL LIKE FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA CONTENT; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO CULTURE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION;

BASE SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; PROMOTER REGIONS, GENETIC; SEQUENCE ALIGNMENT; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

RODENTIA;

EID: 79952504238     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08018.x     Document Type: Article

References (45)

1. Bedard K, &, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313. (Pubitemid 46209993)
2. Lambeth JD, Krause KH, &, Clark RA, (2008) NOX enzymes as novel targets for drug development. Semin Immunopathol 30, 339-363.
3. Katsuyama M, (2010) NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles. J Pharmacol Sci 114, 134-146.
4. Gallin JI, (1993) Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. Int J Tissue React 15, 99-103. (Pubitemid 24038388)
5. Geiszt M, Kopp JB, Varnai P, &, Leto TL, (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97, 8010-8014. (Pubitemid 30460764)
6. Cheng G, Cao Z, Xu X, van Meir EG, &, Lambeth JD, (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131-140. (Pubitemid 32488913)
7. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, &, Sumimoto H, (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276, 1417-1423. (Pubitemid 32096573)
8. Yang S, Madyastha P, Bingel S, Ries W, &, Key L, (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276, 5452-5458.
9. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, &, Griendling KK, (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105, 249-259.
10. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, &, Krause KH, (2007) NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406, 105-114. (Pubitemid 47264740)
11. Zhang L, Sheppard OR, Shah AM, &, Brewer AC, (2008) Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F. Free Radic Biol Med 45, 679-685.
12. Arakawa N, Katsuyama M, Matsuno K, Urao N, Tabuchi Y, Okigaki M, Matsubara H, &, Yabe-Nishimura C, (2006) Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Biochem J 398, 303-310. (Pubitemid 44338487)
13. Katsuyama M, Ozgur Cevik M, Arakawa N, Kakehi T, Nishinaka T, Iwata K, Ibi M, Matsuno K, &, Yabe-Nishimura C, (2007) Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J 274, 5128-5136. (Pubitemid 47481186)
14. Suske G, (1999) The Sp-family of transcription factors. Gene 238, 291-300. (Pubitemid 29446168)
15. Kaczynski J, Cook T, &, Urrutia R, (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4, 206.
16. Li L, He S, Sun JM, &, Davie JR, (2004) Gene regulation by Sp1 and Sp3. Biochem Cell Biol 82, 460-471. (Pubitemid 39286961)
17. Yu B, Datta PK, &, Bagchi S, (2003) Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31, 5368-5376. (Pubitemid 37441905)
18. Bouwman P, Gollner H, Elsasser HP, Eckhoff G, Karis A, Grosveld F, Philipsen S, &, Suske G, (2000) Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J 19, 655-661. (Pubitemid 30093738)
19. Van Loo PF, Bouwman P, Ling KW, Middendorp S, Suske G, Grosveld F, Dzierzak E, Philipsen S, &, Hendriks RW, (2003) Impaired hematopoiesis in mice lacking the transcription factor Sp3. Blood 102, 858-866. (Pubitemid 36917776)
20. van Loo PF, Mahtab EA, Wisse LJ, Hou J, Grosveld F, Suske G, Philipsen S, &, Gittenberger-de Groot AC, (2007) Transcription factor Sp3 knockout mice display serious cardiac malformations. Mol Cell Biol 27, 8571-8582.
21. Gartel AL, Goufman E, Najmabadi F, &, Tyner AL, (2000) Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene 19, 5182-5188.
22. Valin A, Cook JD, Ross S, Saklad CL, &, Gill G, (2009) Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells. Biochim Biophys Acta 1789, 204-211.
23. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y, &, Yuasa Y, (2005) Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385, 557-564. (Pubitemid 40165090)
24. Sun H, Sheveleva E, &, Chen QM, (2008) Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor. Mol Endocrinol 22, 2076-2084.
25. Ehlting C, Haussinger D, &, Bode JG, (2005) Sp3 is involved in the regulation of SOCS3 gene expression. Biochem J 387, 737-745. (Pubitemid 40685708)
26. Ammanamanchi S, Freeman JW, &, Brattain MG, (2003) Acetylated sp3 is a transcriptional activator. J Biol Chem 278, 35775-35780. (Pubitemid 37102354)
27. Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD, Neve R, &, Ratan RR, (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 23, 3597-3606. (Pubitemid 36958467)
28. Lee J, Kosaras B, Aleyasin H, Han JA, Park DS, Ratan RR, Kowall NW, Ferrante RJ, Lee SW, &, Ryu H, (2006) Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response. FASEB J 20, 2375-2377.
29. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Whorton AR, &, Hoidal JR, (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282, C1212-1224. (Pubitemid 34663069)
30. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayama J, Konagai A, (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25, 3699-3707. (Pubitemid 43980491)
31. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, (2006) Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290, L661-L673. (Pubitemid 43725071)
32. Sturrock A, Huecksteadt TP, Norman K, Sanders K, Murphy TM, Chitano P, Wilson K, Hoidal JR, &, Kennedy TP, (2007) Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292, L1543-1555. (Pubitemid 47078930)
33. Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, Yamasaki T, Amano T, Mizoguchi M, Suzuki SO, Niiro H, (2008) Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Int J Cancer 123, 787-792. (Pubitemid 352032403)
34. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, &, Gorin Y, (2008) Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283, 24061-24076.
35. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, (2004) NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 24, 10703-10717. (Pubitemid 39603128)
36. McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, &, Nagarkatti M, (2006) Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol Pharmacol 70, 897-908. (Pubitemid 44268447)
37. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, Schmidt HH, Lassegue B, &, Griendling KK, (2007) Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27, 42-48. (Pubitemid 46360379)
38. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernandez M, &, Fabregat I, (2008) Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 49, 965-976.
39. Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, &, Fabregat I, (2009) Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res 69, 7595-7602.
40. Ago T, Kuroda J, Pain J, Fu C, Li H, &, Sadoshima J, (2010) Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106, 1253-1264.
41. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, &, Sadoshima J, (2010) NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 107, 15565-15570.
42. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, (2010) NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 107, 18121-18126.
43. Nishinaka T, &, Yabe-Nishimura C, (2005) Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 97, 43-51. (Pubitemid 40313098)
44. Nishinaka T, Fu YH, Chen LI, Yokoyama K, &, Chiu R, (1997) A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. Biochim Biophys Acta 1351, 274-286. (Pubitemid 27158424)
45. Katsuyama M, Fan C, Arakawa N, Nishinaka T, Miyagishi M, Taira K, &, Yabe-Nishimura C, (2005) Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem J 386, 255-261. (Pubitemid 40343782)